Increased Total Sales
Total sales reached $4.9 billion in the second quarter, an increase of 5.5% versus the same period last year.
Strong Same-Store Sales Growth
Food same-store sales were up 5.2%, with an adjusted increase of 3.9% accounting for a calendar shift. Pharmacy same-store sales were up 7%.
Improved Gross Margin
Gross margin stood at 20% of sales, up from 19.9% in the same quarter last year.
EBITDA Growth
EBITDA for the quarter totaled $461 million, up 5% year-over-year and 6.8% when excluding asset disposal effects.
Increased Net Earnings
Adjusted net earnings rose to $226.6 million, a 9.8% increase from last year, with adjusted net earnings per share up 12.1%.
Pharmacy Segment Success
Prescription sales were up 7.8%, driven by organic growth, specialty medications, and professional services.
Online Sales Growth
Online sales grew by 26%, driven by click-and-collect services and third-party marketplaces.
Share Repurchase Program
Repurchased 2.849 million shares for $264 million, at an average price of $92.65 per share.